132 related articles for article (PubMed ID: 35665603)
1. Impact of combining vancomycin with proton pump inhibitors on the incidence of acute kidney injury.
Aljohani HA; Alharbi HA; Basurrah SA; Alamoudi SA; Thabit AK
Basic Clin Pharmacol Toxicol; 2022 Sep; 131(3):189-195. PubMed ID: 35665603
[TBL] [Abstract][Full Text] [Related]
2. Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
Tookhi RF; Kabli NA; Huntul MA; Thabit AK
Intern Emerg Med; 2021 Jun; 16(4):975-979. PubMed ID: 33439417
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
4. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
Liu K; Zhang Y; Xu X; Wu B; Ni J; Li T; Xing C; Mao H
Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
[TBL] [Abstract][Full Text] [Related]
6. Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem.
Zhang T; Cheng H; Li Y; Dong YZ; Zhang Y; Cheng XL; Wang AM; Dong YL
J Clin Pharm Ther; 2019 Jun; 44(3):440-446. PubMed ID: 30737860
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney Injury.
Blackman AL; Joshi M; Doub J; Seung H; Banoub M; Claeys KC; Heil EL
Surg Infect (Larchmt); 2021 Oct; 22(8):810-817. PubMed ID: 33571051
[No Abstract] [Full Text] [Related]
8. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
Pan KM; Wu Y; Chen C; Chen ZZ; Xu JA; Cao L; Xu Q; Wu W; Dai PF; Li XY; Lv QZ
Br J Clin Pharmacol; 2018 Aug; 84(8):1706-1718. PubMed ID: 29607531
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
10. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study.
Zhang Y; Ghahramani N; Razjouyan H; Ba DM; Chinchilli VM
BMC Nephrol; 2023 May; 24(1):150. PubMed ID: 37237361
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.
Rutter WC; Burgess DR; Talbert JC; Burgess DS
J Hosp Med; 2017 Feb; 12(2):77-82. PubMed ID: 28182801
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Rutter WC; Burgess DS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
[TBL] [Abstract][Full Text] [Related]
13. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.
Ikuta K; Nakagawa S; Yamawaki C; Itohara K; Hira D; Imai S; Yonezawa A; Nakagawa T; Sakuragi M; Sato N; Uchino E; Yanagita M; Terada T
BMC Nephrol; 2022 Nov; 23(1):383. PubMed ID: 36451129
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Balcı C; Uzun Ö; Arıcı M; Hayran SA; Yüce D; Ünal S
Int J Antimicrob Agents; 2018 Aug; 52(2):180-184. PubMed ID: 29649586
[TBL] [Abstract][Full Text] [Related]
17. Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use.
Yabes JM; Stewart L; Shaikh F; Robben PM; Petfield JL; Ganesan A; Campbell WR; Tribble DR; Blyth DM
J Intensive Care Med; 2021 Jul; 36(7):818-827. PubMed ID: 32508215
[TBL] [Abstract][Full Text] [Related]
18. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
